Considerthe current situation:
1. ENDO is doing the right thing in minimizing the excitement on Urocidin. They have to make sure they do not irg the FDA with their over-confidence lest it might hamper the approval process. FDA has se many precidence in delaying approval because of companies swagger. I think partially is that put pressure on them to cover their rear-ends.
2. It does ENDO no favors to do anything to increace BNC sp even if buy-out is not in their plan. They only need to use the presentation to generate enough referrals for the trial patients. That's why I thing the wording for the presentation is so carefully crafted.
3. Any buy-out offer from ENDO will not happen at least until they have enough patient data in Phase IIIb to give them a 100% assurance thatt Urocidin will get approved. Why should they take any more risk when they have limited their possible loss in the current deal. They can walk away without paying any more milestone payment if things don't look good. And yet, BNC human division cannot go anywhere without Urocidin approval. They have time to wait and see. As long as they don't diculge anymore data, they can also limit the risk of competitive buy-out offers.
As I talked to Johnathan Neely at ENDO as an ENDO shareholder, he says that at this point they feel that there is still some uncertainty of Urocidin approval until more data required by FDA are generated from IIIb. So their attitute is definitely wait and see.
4. BNC cannot really do any aggressive marketing on Econiche in Canada until it has the ability to deliver the stock, aka the vaccine plant become commisioned and operational.
5. BNC cannot divulge any inkling of any lobbying effort for government's mandate or subsidy while it is in process for obviuos political reasons. So they have to remain mum on PR if there should be any.
6. With the Conservatives coming in power, government's intervention of business practice and introduction of any new mandates and regulations that will increase businesses' expense is unlikely.
7. USDA approval of Econiche can be a long wait due to obviuos political and econimic bias to Epitopix.
So what do we have?
1. Econiche need to be aggressively put through the approval process in countries like Australia, Sweden that have already shown more interest in mandating E. Coli vaccines and then market it agressively once the approval is obtained.
2. BNC should continually put out news on E. Coli cases from worldwide to the Canadian public and follow the nes with the availability of Econiche. Put the pressure on the government via citizen's concern and outrage of their not making use of Econiche available already.
3. BNC stated that Canada import all its animal vaccines. They need to aggressively promote the capability of manufacturing all the vaccines being imported and capture tat whole market. That will generate substantial revenue and make good use of the planr while we ar ewaiting for Econiche's commercialisation.
4. BNC should also aggressively promote the MCC platform usage in animal health. There are already drugs developed from this platform approved for animal use. Use them, make their success stories known to public and hint that Urocidin is being tested. That will increase the public awareness of Urocin's potential without stepping on ENDO's restriction on data PR release. When people start hearing MCC curing horses' bladder cancer, they will start to think!
5. If we look a the situation objectively, all the pieces of the jig-saw is there and in place. All we need is time.
6. BNC did the right thing to give ENDO the Urocidin to develop. They have the experience and expertise. They know how to play that complicated game. And they are a U.S. company. BNC has no idea. They could end up strung along and played just like the case of Econiche. Did we give away too much? If BNC keep Urocidin, it might never get approved (at least in U.S.)
At the mean time. BNC will remain the playgroud for the daytraders. Seriuos investors has to hold on together to not sell into this rediculous price.
I am holding on though I am sitting on a $85000 real loss right now :(
GLTA